Søgning


Flere søgeindstillinger

Søgning på udtrykket 'hiv' giver 82 resultater


Dokumenter [21] Sider [7] Kalender [5] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [21]

Europæisk guideline om hvornår, der bør testes for HIV. Udgivet af "HIV in Europe", et paneuropæisk initiativ for tidligere diagnosticering og behandling af HIV. Kort version på dansk kan findes på www.eurotest.org/projects-collaborations/indicator-condition-guided-hiv-testinghides/guidance-hiv-indicator-conditions

Udarbejdet af arbejdsgruppe fra Dansk Selskab for Infektionsmedicin og Dansk Fertilitetsselskab.

Fællesregional retningslinje for udlevering af forebyggende medicin mod HIV (PrEP), udgivet af Danske Regioner.

Udarbejdet af arbejdsgruppe under Dansk Selskab for Infektionsmedicin

Udarbejdet af DSI's arbejdsgruppe vedrørende antiretroviral terapi

Om håndtering og opfølgning for at minimere risiko for smitte med bl.a. HIV, HBV og HCV.

…medicin i form af f.eks TNF-α hæmmere eller andre immunsupprimerende biologiske lægemidler, hvor der er øget risiko for tuberkulosereaktivering. Guideline dækker ikke børn, personer med medfødt immundefekt, HIV positive, patienter i dialyse, patienter med dysreguleret diabetes, silicose, erhvervede immundefekter eller patienter i konventionel kortvarig kemoterapi. Denne guideline omhandler ikke klassisk smitteopsporing blandt tuberkuloseeksponerede eller udredning på mistanke om aktiv tuberkulose.

…r (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner. Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).

Arrangeret af Yngre Infektionsmedicinere

Bl.a. om HIV, hepatitis, resistente bakterier og immundefekt

Bl.a. om HIV, hepatitis, influenza og CNS infektioner

Bl.a. om HIV, hepatitis, cystisk fibrose og nye guidelines

Correspondence regarding "Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy"

DANHIV blev oprettet som en regional klinisk kvalitetsdatabase i RegionH i sommeren 2015. Imidlertid har projektet fungeret som Det Danske HIV Kohorte Studie (DHK) siden 1998. DHK har fungeret som en kombineret kvalitetsdatabase og forskningsdatabase. Data i DHK går tilbage til 1. januar 1995, hvorfor vi allerede nu kan vise udviklingen over en lang årrække for de forskellige indikatorer.

Bl.a. om sygdom efter udlandsrejse, resistens og kroniske virale infektioner

Forfattet af DSI's arbejdsgruppe vedrørende antiviral behandling

Bilag til Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)

Sider [7]

…nter 1). Kort over Hvidovre Hospital: www.hvidovrehospital.dk/praktisk-information/transport/Documents/Kort%20over%20Hvidovre%20Hospital.pdf. Delkursusledere: Ole Søgård og Lene Ryom. Formål: At kursisten skal opnå en forståelse af HIV-infektionen, herunder viden om dens epidemiologi, patogenese, diagnose, forebyggelse, behandlingsmulighederne og prognose…

Formål: At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted: Hvidovre Hospital. Lokale 10 i undervisningsbygningen. Delkursusledere: Ann-Brit Eg Hansen og Ole Kirk. Program: Mandag 3…

…me og biologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet…

…na Weis, Britta Tarp, Lone Mygind National Strategi for Hepatitis C (Sundhedsstyrelsen 2023), Kronisk viral hepatitis: Nina Weis (tovholder), Peer Brehm Christensen, Alex Lund Laursen Hepatitis B (2018), Hepatitis C (2022), HIV: Antiretroviral terapi: Jan Gerstoft (tovholder), Jens Lundgren, Henrik Nielsen, Alex Laursen, Niels Obel, Isik Somuncu, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer (2024), Fertilitetsbehandling ved HIV og…

…ktioner og kronisk hepatitis: Dato for næste kursus. 2026: Sted. Odense Universitetshospital. Delkursusledelse. Lone Mygind, Micha Jepsen og Belinda Mössner. Tidligere kurser. 4. og 5. december 2023. 3. og 4. december 2020. HIV-infektion: Næste kursus. 30. og 31. oktober 2025 (2 dage): Sted. Aarhus Universitetshospital (AUH) . Delkursusledelse. Ole Schmeltz Søgaard og Lene Ryom Nielsen . Program. Afventer. Tidligere kurser. 12. og 13. oktober 2022…

…me og biologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet…

…iklen summerer på en rimelig afbalanceret måde den globale kontrovers, som 2013 var præget af, om hvorvidt ART skal benyttes som forebyggende middel, som led i en individuel-baseret eller en folkesundsbaseret strategi for at reducere smittespredning af HIV

Professor Henrik Nielsen kommenterer: Trods indiskutable fremskridt i den farmakologiske behandling af HIV/AIDS er der fortsat områder med plads til forbedring. Blandt patienter i kronisk behandling er HAND (HIV-associated neurocognitive disorder) et af disse eksempler…

Professor Jens Lundgren kommenterer: I 2014 var verden optaget af Ebola udbruddet i Vest Afrika – et udbrud der blev erkendt hurtigt (om end den internationale assistance lod vente på sig). Vedlagte artikel belyser detaljeret hvorledes HIV pandemien startede i 1920’erne og hvor det jo som bekendt tog over 60 år af finde ud at der overhovedet var et problem. Synes artiklen er godt skrevet og giver et indblik i Afrika for 90 års siden og de ingredienser der skulle til for at ud…

Professor Lars Østergaard kommenterer: Jeg vil gerne anbefale vedlagte artikel som julemånedslæsning. Grundene er som følger: 1) Det vises for første gang, at et medikament kan reaktivere latent HIV-virus under samtidig HAART-behandling i en grad, så virus kan påvises i perifert blod. 2) Der er (omend videnskaligt svage) indicier på, at HIV-reservoir kan reduceres hos nogle patienter, og at effekten af det innate immunforsvar er af betydning herfor…

Professor Jens Lundgren kommenterer: I 2015 nåede WHO sit mål om at få 15 million på behandling. START studiet afklarede også at alle HIV+ personer har gavn af at starte på HIV behandling. Der er fortsat mere end 20 millioner der endnu ikke er startet. Hovedparten bor i ressource svage lande hvor adgang til monitorering af HIV mængden er begrænset og behandlingsskift pga behandlingssvigt er derfor primært drevet af klinik og CD4 tals måling…

… dolutegravir, især når det kombineres med TAF fremfor tenofovir DF, forårsager markant vægtøgning. Især hos kvinder med mørk hudfarve. Artiklen gør indtryk af en række grunde:. Da dolutegravir blev markedsført havde det profilen som det eneste HIV præparat uden bivirkninger. Læring: der er ingen medicinske præparater der ikke har nogle bivirkninger, og typen af bivirkninger kan ikke altid forudsiges udfra markedsføringsstudier (fase I-III)…

Professor Jens Lundgren kommenterer: Første lægemiddel mod SARS-CoV-2 udviklet fra ”bunden” – bruger et gammel trick fra HIV medicinen (ritonavir) for at holde plasma koncentrationerne oppe. Læringen er, at det tager tid at lave nye lægemidler helt fra bunden, men det er noget nær en verdensrekord så hurtigt som det skete under pandemien – både hvad angår vacciner (hvor det tog < 1 år fra design ex vivo til markedsføring), men altså ca 2 år for lægemidler som dette.

Professor Lars Østergaard kommenterer: Indimellem kommer der studier, som er så overbevisende, at det sætter en ny behandlingsstandard. Det kan f.eks…

Professor Troels Lillebæk kommenterer: Interessant systematisk review i AIDS om udbytte af screening for tuberkulose infektion (TBI) blandt personer, der lever med HIV (PLHIV) i tuberkulose lav-incidens lande (som Danmark) . Inddraget i alt 51 undersøgelser med 65.930 PLHIV hvoraf 12 % havde en positiv LTBI-test, som var stærkt relateret til oprindelsesland og eksponering for TB )…


Kalender [5]
30. oktober, Aarhus Universitetshospital (AUH)
24. september, Stockholm, Sverige
13. juni, Panum instituttet, København
4. juni, Barcelona, Spanien
Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?

BMJ Open
24.05.2025
. Objectives. This study aimed to understand antiretroviral therapy (ART) adherence norms and beliefs among men living with HIV (MLHIV) in Mozambique, gauge the impact of misconceptions and harmful beliefs, evaluate perceived HIV service quality and assess the effectiveness of a behaviour change campaign (Somos Iguais), particularly among men aged 25–34 years. . Design. A mixed-methods, cross-sectional study using quantitative and qualitative approaches. . Setting…
BMJ Open
24.05.2025
. Introduction. The capacity of a health system to fulfill the justifiable demands of patients and their caregivers while delivering prompt, courteous and patient-centered treatment is known as health system responsiveness (HSR). HSR can be considered as a measure for the quality of the health system. Keeping aside the clinical aspects of healthcare, it focusses on the health system’s capacity to meet the needs of patients in accordance with ethical values and service standards…
BMJ Open
24.05.2025
. Introduction. People living with HIV/AIDS (PLWHA) have complex physical, psychological, social and spiritual needs following diagnosis and poorer health-related quality of life than the general population. Holistic assessment and care delivery incorporating person-centred principles is required to address these needs…
BMC Infectious Diseases
24.05.2025
. Background. Every day, over a million sexually transmitted infections (STIs) are contracted worldwide, with Sub-Saharan Africa having the highest share of STIs. This study aimed to determine the prevalence of HIV, HBV, and reported STI-related syndromes during the Tigray war, considering the potential for increased transmission. . Methods…
BMC Infectious Diseases
24.05.2025
. Background. Virological outcome is a critical determinant of care in HIV management, as highlighted in the third portion of the UNAIDS 95–95-95 fast-track targets, emphasizing viral load suppression as an essential strategy for epidemiological control of HIV by 2030. There have been various reports regarding Nigeria's recent position, particularly concerning viral load suppression…
PLoS One Infectious Diseases
24.05.2025
by José C. Langa, Mohsin Sidat, Jahit Sacarlal, Troy D. Moon . Laboratory diagnosis for cryptococcal disease among HIV-infected patients remains a challenge in most low- and middle-income countries (LMIC). Difficulties with sustained access to cryptococcal rapid tests is cited as a major barrier to the routine screening for cryptococcus in many LMIC. Thus, clinicians in these countries often resort to empirical treatment based solely on clinical suspicion of cryptococcosis…
Journal of Acquired Immune Deficiency Syndromes
22.05.2025
Background: . The effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV depends on consistent use, particularly during periods of increased risk. Depression, which disproportionately affects gay, bisexual, and other men who have sex with men (GBMSM), may hinder sustained PrEP engagement. This study examines how depression impacts consistent PrEP use among GBMSM in the first 18 months after initiating oral PrEP. Methods: …
Journal of Acquired Immune Deficiency Syndromes
22.05.2025
Introduction: . Evidence is needed to inform differentiated service delivery models for people with HIV (PWH). During the COVID-19 pandemic, South Africa temporarily changed the validity of repeat prescriptions for ART from 6 to 12 months. We evaluated the association between these changes and HIV viral non-suppression in the private health sector. Methods: . We analysed routine claims data from a large private-sector HIV management programme…
PLoS One Infectious Diseases
20.05.2025
by Marlou J. Jongkees, Susanne Bogers, Rory D. de Vries, Corine H. GeurtsvanKessel, Pedro Miranda Afonso, Kathryn S. Hensley, Bart J. A. Rijnders, Kees Brinkman, Casper Rokx, Anna H. E. Roukens . Background Although guidelines for COVID-19 additional vaccination strategies generally prioritise people with advanced HIV infection, recommendations vary globally, with some countries recommending an annual vaccination for all people with HIV (PWH), while others restrict this to PWH with a CD4+ T-cell count 
AIDS
19.05.2025
Objective: . To evaluate impacts of Shamba Maisha, a climate-smart agriculture intervention, on agricultural and nutrition outcomes of people with HIV. Design: . Secondary analysis of a parallel, non-blinded cluster-randomized controlled trial. Setting: . Western Kenya. Participants: . Clusters were clinics providing HIV services to >350 patients…
AIDS
19.05.2025
Objective: . Adverse childhood experiences (ACEs) are traumatic events occurring before age 18 and can increase cardiovascular disease (CVD) risk. Many sexual minority men (SMM) and men living with HIV (MLWH) have trauma histories and elevated CVD risk. We investigated the association between ACEs and CVD risk among SMM living with and without HIV (MLWH and MLWOH). Design and methods: . Data were from the Multicenter AIDS Cohort Study (n = 1245; n = 650 MLWOH, n = 595 MLWH)…
AIDS
19.05.2025
Objectives: . To evaluate the potential contributions of routine opt-out testing (ROOT) in clinical settings and preexposure prophylaxis (PrEP) on achieving Ending the HIV Epidemic in the U.S. (EHE) incidence reduction goals in the South. Design: . Simulation Study . Methods: . An agent-based epidemic projection model simulated adherence to the CDC's ROOT guidelines. Simulations were informed by literature reviews, the National Survey of Family Growth and ARTnet…
Malaria Journal
16.05.2025
. Background. Africa bears the highest double burden of HIV and malaria worldwide. In 2023, an estimated 25.9 million people were living with HIV (PLHIV), and 246 million malaria cases were diagnosed in Africa. Malaria patients co-infected with HIV are considered at a higher risk of failing malaria treatment, according to the World Health Organization (WHO) guidelines…
BMJ Open
16.05.2025
. Objective. Adolescents and young adults (AYA) with HIV are a population at high risk of experiencing mental issues and sleep disorder. We aim to summarise the global prevalence and risks of depression, anxiety, post-traumatic stress disorder (PTSD) and sleep disorder among AYA with HIV. . Design. Systematic review and meta-analysis. . Data sources. PubMed, Web of Science, Embase and PsycINFO were searched from inception to 3 August 2024. . Eligibility criteria…
BMC Infectious Diseases
16.05.2025
. Background. Youth in southern Africa continue to be at high risk of HIV infection. We investigated the awareness of, access to, and uptake of HIV prevention interventions (pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), voluntary medical male circumcision and condoms) among youth in Zimbabwe. . Methods…
Tropical Medicine & International Health
16.05.2025
Tropical Medicine &International Health, EarlyView.
PLoS One Infectious Diseases
16.05.2025
…vanced HIV disease. In the era of Universal Test and Treat (UTT) policy, most PLWH start ART early with high CD4 counts. Therefore, we investigated the association between baseline CD4 count with QoL and retention among PLWH during UTT in southwestern Uganda. Methods Between June 11, 2019, and June 10, 2020, we reviewed medical records for PLWH initiated on ART between April 2017 and September 2018 and interviewed them to collect QoL data. The primary exposure was CD4 count at ART initiation categorized as
Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?

Medscape Infectious Diseases
24.05.2025
The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, resulting in chain termination. . Medscape Medical News
Medscape Infectious Diseases
14.05.2025
Testing and monitoring of HIV patients across South Africa have fallen since the United States cut aid that funded health workers and clinics, with pregnant women, infants. . Reuters Health Information
Medscape Infectious Diseases
14.05.2025
A game-changing program that identified thousands of new HIV cases is targeted to close ahead of schedule. . Medscape Medical News
Medscape Infectious Diseases
13.05.2025
A machine learning model outperformed biological tests for latent TB in identifying HIV-positive people at high risk of developing TB in Switzerland. . Medscape Medical News
Eurosurveillance latest updates
9.05.2025
. Background. HIV testing based on indicator conditions is recommended to diagnose HIV earlier. . . Aim. Our aim was to assess opportunities for earlier diagnosis of HIV. . . Method. This is a retrospective study on people living with HIV (PLWH) included in the national HIV register…
Medscape Infectious Diseases
8.05.2025
A cross-sectional analysis shows that long-acting antiretroviral therapy sustains viral suppression regardless of initial viremia in patients with HIV. . Medscape Medical News
Morbidity and Mortality Weekly Report (MMWR)
7.05.2025
CDC updates HIV nonoccupational postexposure prophylaxis recommendations Meta Keywords:
Medscape Infectious Diseases
7.05.2025
AIDS-related illnesses continue to be the most common cause of hospital admissions for people living with HIV worldwide, followed by bacterial infections, a meta-analysis shows. . Medscape Medical News
Medscape Infectious Diseases
29.04.2025
Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression than those in non-redlined areas. . Medscape Medical News
Medscape Infectious Diseases
16.04.2025
Despite being effective, PrEP uptake in Europe remains low due to issues like cost, access, and stigma, hindering its potential to reduce HIV transmission. . Medscape Medical News
ProMED
11.04.2025
. . . HIV/AIDS - INDIA (03): (UTTARAKHAND). ************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . [1] . Date: Wed 9 Apr 2025 . Source: The Times of India (TOI), Times News Network (TNN) [edited] . timesofindia.indiatimes.com/city/dehradun/23-haridwar-jail-inmates-hiv-positive-dm-seeks-report/articleshow/120136259.cms . . …
Medscape Infectious Diseases
11.04.2025
-The Trump administration plans to remove all the members of a presidential advisory council on HIV/AIDS and provided no timeline for replacing them as the government. . Reuters Health Information
Medscape Infectious Diseases
9.04.2025
Global progress against HIV is at risk as aid cuts could trigger millions of new infections and deaths, potentially setting efforts back to 2010 levels, experts warn. . Medscape Medical News
Medscape Infectious Diseases
9.04.2025
Patients who lose medication access will experience disease progression and risk for death, experts emphasize. . Medscape Medical News
ProMED
1.04.2025
. . . HIV/AIDS - INDIA (02): (TRIPURA, KERALA). ****************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . In this post: . [1] Tripura . [2] Kerala . . ****** . [1] Tripura . Date: Wed 26 Mar 2025 . Source: The Indian Express [edited] . indianexpress.com/article/india/tripura-hiv-adults-assembly-cm-manik-saha-9907180/ . . …
Medscape Infectious Diseases
1.04.2025
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it liable in a whistleblower lawsuit for illegally. . Reuters Health Information
Medscape Infectious Diseases
28.03.2025
Nucleoside reverse transcriptase inhibitor resistance does not affect efficacy when adults with HIV suppressed on bPI-based regimen switch to bictegravir plus emtricitabine plus tenofovir alafenamide. . Medscape Medical News
Medscape Infectious Diseases
25.03.2025
There could be 2,000 new HIV infections a day across the world and a ten-fold increase in related deaths if funding frozen by the United States is not restored or replaced,. . Reuters Health Information
Morbidity and Mortality Weekly Report (MMWR)
20.03.2025
This report describes adolescent girls and young women with functional disabilities had who higher prevalence of experiencing sexual, physical and emotional violence.
Medscape Infectious Diseases
20.03.2025
Doubling the dose of tuberculosis treatment did not drive up rates of depression and anxiety. . Medscape Medical News

DSI på

Følg os på linkedin.com/company/dansk-selskab-for-infektionsmedicin

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2025 Dansk Selskab for Infektionsmedicin

CVR: 33634307

infmed.dk
Version: 2.2.1
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 1.159 s

Cookies og privatliv